Cite
AKR1C3 is a biomarker and druggable target for oropharyngeal tumors
MLA
Francesca Guana, et al. AKR1C3 Is a Biomarker and Druggable Target for Oropharyngeal Tumors. Jan. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....f35439cbe319cb6a7e97ff88f667333a&authtype=sso&custid=ns315887.
APA
Francesca Guana, Andrea Carenzo, Ilaria Gregnanin, Paolo Aluffi-Valletti, Gianluca Averono, Agnese Chiara Pippione, Laura Masini, Maurizia Mello-Grand, Guido Valente, Paola Ostano, Simonetta Oliaro-Bosso, Giovanna Chiorino, Loris De Cecco, Marco Krengli, Riccardo Dosdegani, Paolo Bagnasacco, Stefano Cavalieri, Caterina Peraldo-Neia, Arianna Micali, … Federica Perrone. (2021). AKR1C3 is a biomarker and druggable target for oropharyngeal tumors.
Chicago
Francesca Guana, Andrea Carenzo, Ilaria Gregnanin, Paolo Aluffi-Valletti, Gianluca Averono, Agnese Chiara Pippione, Laura Masini, et al. 2021. “AKR1C3 Is a Biomarker and Druggable Target for Oropharyngeal Tumors,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....f35439cbe319cb6a7e97ff88f667333a&authtype=sso&custid=ns315887.